Recent in Europe (page 7 of 8)

SCCP Reviews Hair Dyes

In Europe, the Scientific Committee on Consumer Products (SCCP) has been busy reviewing the components of hair dyes. On Dec. 13, 2005, the committee issued its opinion on the exposure and reaction products of oxidative hair dye formulations. For chemists interested in the chemistry of oxidative hair dyes, this is an excellent review of the various chemical reactions that result in hair dyeing.

Hair Dye Ingredients In Question

Henna and hair dye may be in trouble.

Colipa Welcomes Sunscreen Product Consultation

Colipa welcomes the European Commission’s plan for a public consultation on the drafted “Recommendation on the Efficacy of Sunscreen Products” and related claims.

EFfCI Publishes GMP Guide for Cosmetic Ingredients

The European Federation for Cosmetic Ingredients (EFfCI) released its Good Manufacturing Practice (GMP) Guide.

EU to Move Forward with Research Funding Program

The leaders of the European Union (EU) reportedly plan to move forward making a decision regarding the region's R&D funding program.

European Commission Approves Fentanyl HCl Iontophoretic Transdermal System

The European Commission has granted marketing authorization in the 25 member states of the European Union for the use of Fentanyl hydrochloride (HCl) Iontophoretic Transdermal System (ITS) 40 mcg/dose...

EUROPEN Publishes Packaging Standards Guide

EUROPEN has published a new edition of its guide to assist personal care manufacturers with packaging standards and regulations.

European Adaptation to Technical Progress

Starting with January 2003, The European Union discontinued the numbering of their Adaptation to Technical Progress (ATP). This was done as the 7th Amendment superceded some of the approved ATP’s and made the numbering system out of sync. Since I last reported on the 7th Amendment changes, the EU Commission has issued two critical changes. ATP’s are the way to change the Annexes in the Cosmetic Directive.

US and EU Regulations Update

United States – OTC Drug Review Call for Data On December 31, 2003, the FDA announced a call for data for an OTC drug review, for drugs that have not been reviewed as of this date. These include drugs sold before 5/11/72 (when the OTC drug review began) and identified by OTC category. Also included are OTC drugs marketed before 12/4/75 and described the DA’s general regulatory policy. The call for data covers these categories of ingredients, some of which have been considered to be cosmetics, not drugs: nasal moisturizer drug products, urinary analgesic/antiseptic drug products, urinary acidifiers and alkalinizers, aloe vera and urea, wrinkle remover products, lubricants and vaginal moisturizers.

Updates from Europe and the United States

European Updates The European Union (EU) Commission has not issued any changes to the Annexes of the Cosmetic Directive since September 2003 and lags in publishing many changes that have been approved. Adaptation to Technical Progress (opinions put through the EU and Ad Hoc committee review process) will be further delayed because they must be published in all EU languages. As of May 2004, the EU expanded from 15 to 25 countries, complicating the translation list.

Effect of New Regulations on Hair Colouring Products in the EU

The author suggests that current and evolving regulations may lead to a positive list and fewer allowed raw materials for hair colouring products in the European Union.

Industry Updates in the European Union

Since my last column on Europe,1 the European Union (EU) Commission issued two new Adaptations to Technical Progress (ATP) and the EU’s Scientific Committee on Consumer Products (SCCP) issued several opinions. There was some good news and some bad news.

Can't find what you're looking for? Try searching, or looking through past issues.